POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

Código QR

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Yan‐Xing Chen, Zi‐Xian Wang, Shu‐Qiang Yuan, Teng‐Jia Jiang, You‐Sheng Huang, Rui‐Hua Xu, Feng Wang, Qi Zhao
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b915738d37a5444facd0e60cedcf9b20
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort
por: Nikhat Khan, et al.
Publicado: (2017)

A domain in human EXOG converts apoptotic endonuclease to DNA-repair exonuclease
por: Michal R. Szymanski, et al.
Publicado: (2017)

Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors
por: Hee Sang Hwang, et al.
Publicado: (2021)

Indicators of responsiveness to immune checkpoint inhibitors
por: Bradley D. Shields, et al.
Publicado: (2017)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
por: Zheng-Hang Wang, et al.
Publicado: (2018)

Shared active site architecture between archaeal PolD and multi-subunit RNA polymerases revealed by X-ray crystallography
por: Ludovic Sauguet, et al.
Publicado: (2016)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Sireesha Upadhrasta, et al.
Publicado: (2019)

Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Publicado: (2021)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
por: Di Wang, et al.
Publicado: (2021)

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
por: Claire Vanpouille-Box, et al.
Publicado: (2017)

Dynamic coordination of two-metal-ions orchestrates λ-exonuclease catalysis
por: Wonseok Hwang, et al.
Publicado: (2018)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Ben‐Yuan Jiang, et al.
Publicado: (2021)

Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
por: Can Öztürk, et al.
Publicado: (2021)

A decade of immune-checkpoint inhibitors in cancer therapy
por: Caroline Robert
Publicado: (2020)

The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole
por: Kara Martin, et al.
Publicado: (2021)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Pan Shen, et al.
Publicado: (2021)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou W, et al.
Publicado: (2021)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Nicola Personeni, et al.
Publicado: (2021)

Acute kidney injury in patients treated with immune checkpoint inhibitors
por: Enriqueta Felip, et al.
Publicado: (2021)

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
por: Zhenghang Wang, et al.
Publicado: (2021)

MutL sliding clamps coordinate exonuclease-independent Escherichia coli mismatch repair
por: Jiaquan Liu, et al.
Publicado: (2019)

The exonuclease Xrn1 activates transcription and translation of mRNAs encoding membrane proteins
por: Bernat Blasco-Moreno, et al.
Publicado: (2019)

Non-permanent Pole-to-pole Fault Restoration Strategy for Flexible DC Distribution Network
por: Zainan Li, et al.
Publicado: (2021)

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors
por: Romel Somwar, et al.
Publicado: (2020)

Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study
por: Xiaozhun Huang, et al.
Publicado: (2021)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
por: James Harber, et al.
Publicado: (2021)

The roles of exosomal immune checkpoint proteins in tumors
por: Cheng Xing, et al.
Publicado: (2021)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Andrew Haydon, et al.
Publicado: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Zoe Apalla, et al.
Publicado: (2021)

Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy
por: Selina K. Wong, et al.
Publicado: (2021)

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
por: Yingyan Yu
Publicado: (2021)

Progress of Immune Checkpoint Inhibitors  in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
por: Haoqing CHEN, et al.
Publicado: (2021)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Linda Wu, et al.
Publicado: (2021)

Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study
por: Anne R Bass, et al.
Publicado: (2021)

Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
por: ZHU Kuikui, et al.
Publicado: (2021)

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Kimberly M. Burcher, et al.
Publicado: (2021)

A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links
por: Alex M. Andrews, et al.
Publicado: (2018)

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
por: Chiao-Fang Teng, et al.
Publicado: (2020)

Effect of pole size on preservative penetration and retention in air-dried ugandan grown eucalypt utility poles
por: Mugabi,Paul, et al.
Publicado: (2018)

Highly Sensitive and Selective Copper (II)-Catalyzed Dual-DNAzyme Colorimetric Biosensor Based on Exonuclease III-Mediated Cyclical Assembly
por: Baiqiang Zhai, et al.
Publicado: (2021)